stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) Gross margin
Prestige Consumer Healthcare Inc.'s gross margin over the twelve months to 30 September 2026 was 52.5%, down 2.2 percentage points from fiscal 2026 (54.7%). Over the past ten years it has ranged from 54.7% (fiscal 2026) to 58.0% (fiscal 2021) — the current reading is the lowest in ten years. That is in line with the Drug Manufacturers Specialty & Generic industry median of 53.5% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 54.7% | (1.05) |
| FY2025 | 55.8% | 0.27 |
| FY2024 | 55.5% | 0.04 |
| FY2023 | 55.5% | (1.66) |
| FY2022 | 57.1% | (0.92) |
| FY2021 | 58.0% | 0.69 |
| FY2020 | 57.3% | 0.40 |
| FY2019 | 56.9% | 1.57 |
| FY2018 | 55.4% | (1.35) |
| FY2017 | 56.7% | (1.23) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 51.3% | 0.05 |
| Jun 2026 | 51.3% | (0.70) |
| Mar 2026 | 52.0% | (3.57) |
| Dec 2025 | 55.5% | 0.22 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | 97.9% |
| XERS Xeris Biopharma Holdings, Inc. compare | 87.4% |
| TRLV Trulieve Cannabis Corp. compare | 60.6% |
| PBH Prestige Consumer Healthcare Inc. | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| ALVO Alvotech compare | 42.7% |
| PRGO Perrigo Company plc compare | 32.3% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −42.7% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement